Organism name | Aralia elata |
---|---|
Genus | Aralia |
Family | Araliaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Aralia elata |
---|---|
Linked NCBI taxonomy ID | 82095 |
Linked level | species |
Family in NCBI taxonomy | Araliaceae |
---|---|
ID | 4050 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00006655
![]() |
Cyanidin 3-lathyroside
|
No. 1 | No. 15 |
![]() |
||||
C00036736
![]() |
Congmunoside V
/ Araliasaponin V |
No. 4 | No. 51 |
![]() |
||||
C00036738
![]() |
Congmunoside VII
/ Araliasaponin VII |
No. 4 | No. 51 |
![]() |
||||
C00037850
![]() |
Stipuleanoside R2
|
CHEMBL1288836
|
No. 4 | No. 51 |
![]() |
|||
C00036737
![]() |
Araliasaponin VI
|
No. 4 | No. 51 |
![]() |
||||
C00032716
![]() |
Aralia-saponin IV (Aralia elata)
/ (-)-Aralia-saponin IV (Aralia elata) |
No. 4 | No. 51 |
![]() |
||||
C00036739
![]() |
Araliasaponin VIII
|
No. 4 | No. 51 |
![]() |
||||
C00036735
![]() |
Congmunoside IX
/ Araliasaponin IX |
No. 4 | No. 51 |
![]() |
||||
C00032935
![]() |
Elatoside F
/ Tarasaponin VII |
C102413
|
No. 4 | No. 51 |
![]() |
|||
C00032934
![]() |
Elatoside C
|
CHEMBL1833984
|
3 / 5 / 3 | No. 4 | No. 51 |
![]() |
||
C00032854
![]() |
Congmuyenoside B
/ (+)-Congmuyenoside B |
No. 4 | No. 51 |
![]() |
||||
C00032715
![]() |
Araliasaponin III (Aralia elata)
/ (-)-Araliasaponin III (Aralia elata) |
No. 4 | No. 51 |
![]() |
||||
C00032814
![]() |
Araloside A
/ Chikusetsusaponin IV |
CHEMBL1773982
|
C071578
|
No. 9 | No. 51 |
![]() |
||
C00032800
![]() |
Calenduloside G
/ (+)-Calenduloside G |
CHEMBL503302
|
No. 9 | No. 51 |
![]() |
|||
C00037849
![]() |
Stipuleanoside R1
|
No. 9 | No. 51 |
![]() |
||||
C00032714
![]() |
Araliasaponin II (Aralia elata)
|
No. 9 | No. 51 |
![]() |
||||
C00032933
![]() |
Elatoside A
/ Tarasaponin II |
No. 9 | No. 51 |
![]() |
||||
C00032713
![]() |
Araliasaponin I (Aralia elata)
/ (-)-Araliasaponin I (Aralia elata) |
No. 9 | No. 51 |
![]() |
||||
C00031755
![]() |
Durupcoside C
/ (+)-Durupcoside C |
No. 9 | No. 51 |
![]() |
||||
C00003528
![]() |
Sapindoside A
/ alpha-Hederin / (+)-Sapindoside A / Kalopanaxsaponin A / (+)-Kalopanaxsaponin A / Hederagenin 3-O-alpha-L-rhamnopyranosyl(1->2)-alpha-L-arabinopyranoside |
CHEMBL447565
CHEMBL503131 CHEMBL525085 CHEMBL1437395 CHEMBL1980760 |
C010177
|
4 / 18 / 47 | No. 9 | No. 51 |
![]() |
|
C00036929
![]() |
Congmuyenoside A
|
No. 9 | No. 51 |
![]() |
||||
C00003554
![]() |
Spinasaponin A
|
CHEMBL503302
|
No. 9 | No. 51 |
![]() |
|||
C00031687
![]() |
Collinsonidin
/ Hederagenin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-arabinopyranoside |
No. 9 | No. 51 |
![]() |
||||
C00003518
![]() |
Ginsenoside Re
|
CHEMBL510095
|
C049864
|
2 / 0 / 0 | 0 / 1 | No. 11 | No. 51 |
![]() |
C00030395
![]() |
Ginsenoside Rb2
|
CHEMBL449303
CHEMBL507688 CHEMBL452438 |
C048026
|
2 / 0 / 0 | No. 11 | No. 51 |
![]() |
|
C00002631
![]() |
(+)-Lirioresinol B
/ (+)-Syringaresinol |
CHEMBL361362
CHEMBL402653 |
C042192
|
1 / 0 / 0 | No. 38 | No. 21 |
![]() |
|
C00003538
![]() |
Silphioside F
/ Calenduloside E / (+)-Silphioside F / (+)-Calenduloside E / Oleanoic acid 3-O-glucuronide |
CHEMBL446866
CHEMBL1974914 |
No. 50 | No. 51 |
![]() |
|||
C00049544
![]() |
Aralia cerebroside
|
No. 80 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P11387 | DNA topoisomerase 1 | Isomerase | C00002631 C00003518 C00030395 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003518 C00030395 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00003528 | 7 / 37 |
P02545 | Prelamin-A/C | Unclassified protein | C00003528 | 11 / 10 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00003528 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00032934 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00032934 | 5 / 3 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00003528 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00032934 | 0 / 0 |
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
%606641 | Body mass index; bmi |
P37231
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#601665 | Obesity |
P37231
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
KEGG | name | UniProt |
---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|